My SciELO
Services on Demand
Journal
Article
Indicators
- Cited by SciELO
- Access statistics
Related links
- Cited by Google
- Similars in SciELO
- Similars in Google
Share
Revista de Osteoporosis y Metabolismo Mineral
On-line version ISSN 2173-2345Print version ISSN 1889-836X
Abstract
MALDONADO, G; MESSINA, O; MORENO, M and RIOS, C. Osteoporosis in rheumatic diseases and glucocorticoid induced. Rev Osteoporos Metab Miner [online]. 2017, vol.9, n.1, pp.38-49. ISSN 2173-2345. https://dx.doi.org/10.4321/s1889-836x2017000100007.
Osteoporosis is a systemic skeletal disease characterized by low bone mineral density, changes in bone microarchitecture and increased risk of fracture. It has been shown that depends on physiological processes and secondary to other pathologies and associated with the use of glucocorticoids, the latest being the most common cause of osteoporosis associated to drugs, this may be represent a great magnitude public health issue. This review is presented in order to emphasize the clinical importance of osteoporosis in rheumatic diseases and glucocorticoid-induced osteoporosis.
Keywords : osteoporosis; rheumatic diseases; glucocorticoids.